There are a few limitations to Lu-dotatate therapy. The treatment is quite expensive and complex in terms of administration. Ongoing clinical trials are comparing Lu-dotatate therapy with other targeted systemic treatments. Also, this is available at tertiary centers, and that would be limited its widespread availability. The optimal selection of the candidates has been challenging.